Filing Details
- Accession Number:
- 0001237899-14-000034
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-18 17:09:36
- Reporting Period:
- 2014-03-17
- Filing Date:
- 2014-03-18
- Accepted Time:
- 2014-03-18 17:09:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1174475 | S Michael Brown | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-03-17 | 2,000 | $33.42 | 16,662 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-03-17 | 1,100 | $333.42 | 15,562 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-17 | 500 | $334.59 | 15,062 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-17 | 100 | $335.69 | 14,962 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-17 | 300 | $336.49 | 14,662 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-03-17 | 2,000 | $0.00 | 2,000 | $33.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,000 | 2021-01-03 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,700 | Indirect | by Trust 2 |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 1,100 shares of Company stock on March 17, 2014 at prices ranging from $333.04 to $333.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2014 at each separate price.
- Represents volume-weighted average price of sales of 500 shares of Company stock on March 17, 2014 at prices ranging from $334.46 to $334.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 17, 2014 at each separate price.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
